1-Chloro-3-(phenylethynyl)benzene, 97%, 100mg

N-Benzylquinidinium Chloride [Chiral Phase-Transfer Catalyst]>98.0%(T)5g

tert-Butyl 3,8-diazabicyclo[3.2.1]octane-8-carboxylate hydrochloride, 95+%, 5g

N-(3-Bromo-4-fluorophenyl)methanesulfonamide, 95.0%, 5g

2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-methyl-1H-indol-3-yl)propanoic acid, 98%, 250mg

(S)-Methyl morpholine-2-carboxylate hydrochloride, 95.0%, 100mg

4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride, 99.0%, 1g

8-Oxododecanoic acid, 97.0%, 250mg

Methyl 2,4-dichloronicotinate, 95.0%, 250mg

tert-Butyl 6-bromo-4-oxospiro[chroman-2,4'-piperidine]-1'-carboxylate, 95.0%, 5g

ROTI®Cell DPBS, 1 l

HPLC connecting hose inner x outer Ø 0.8 x 1.6 mm (Inch x Inch), 250 mm, 1 Piece

2-Methoxy-4-(4-morpholinopiperidin-1-yl)aniline, 98%, 1g